Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Addwize
Oslo, Norway
A
1-10 Employees
2021
Key takeaway
Addwize conducts discovery studies to enhance understanding of how employees engage with the company's digital infrastructure, which could be relevant for optimizing processes in AI drug discovery. Their expertise in managing digitalization projects and configuring PLM and ERP systems positions them as valuable partners in integrating advanced technologies into workflows.
Reference
Core business
Advice and Discovery - Addwize
Addwize does discovery studies to get a better understanding of how employees execute day-to-day responsibilities within the company’s digital infrastructure.
MIM PHARMA
Oslo, Norway
A
11-50 Employees
2013
Key takeaway
The company is a science-driven organization focused on improving human health through innovative medical solutions. They have developed a natural plant-based antiviral and immune-enhancing treatment for COVID-19 and influenza, utilizing advanced machine learning and systems biology approaches to enhance their research and development processes.
Reference
Product
Technology – MIM PHARMA
In-Virtualis
Oslo, Norway
A
1-10 Employees
-
Key takeaway
In-Virtualis is focused on advancing molecular modeling and simulation technologies, which can significantly reduce the time and cost of drug discovery and vaccine development by 30 to 50%. Their development of a next-generation Computer Aided Molecular Design (CAMD) workstation aims to enhance precision and efficiency in the biotech lab, addressing critical needs in areas like drug discovery and cancer immunotherapy.
Reference
Core business
Home | In-Virtualis
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Integrated Detector Electronics SA
Oslo, Norway
A
11-50 Employees
1992
Key takeaway
IDEAS has over 20 years of experience in developing advanced technology, which could be relevant for innovative applications like AI in drug discovery.
Reference
Core business
Company – IDEAS
BerGenBio
Bergen, Norway
A
11-50 Employees
2007
Key takeaway
BerGenBio is a clinical-stage biopharmaceutical company focused on developing innovative drugs for aggressive diseases, particularly cancer, through its highly selective AXL inhibitors.
Reference
Core business
BerGenBio - Developing first-in-class AXL inhibitors for aggressive disease
Age Labs
Oslo, Norway
A
1-10 Employees
2017
Key takeaway
Age Labs is a Norwegian life science company that utilizes advanced machine learning on epigenetic datasets to develop biomarkers for the early detection of age-related diseases. Their approach includes the analysis of DNA methylation, which is relevant for identifying disease risk and potentially applicable in drug discovery.
Reference
Service
Our Service
Epigenetic reports, data analysis and biomarker development. We measure DNA methylation in immune cells using Illumina microarrays, analyzing 850,000 CpG sites, covering 99% of the RefSeq genes.
AlgiPharma
Sandvika, Norway
A
11-50 Employees
2006
Key takeaway
AlgiPharma is a biopharmaceutical company focused on developing innovative alginate technologies to create new therapeutic options, particularly targeting unmet medical needs. Their expertise and extensive collaboration network enhance their capability in drug delivery and development, making them a key player in advancing healthcare solutions.
Reference
Product
Technology - AlgiPharma
AlgiPharma's alginate oligomers normalize cystic fibrosis sputum, disrupt biofilms and reduce bacterial virulence
PubGene
Oslo, Norway
A
11-50 Employees
2001
Key takeaway
PubGene AS specializes in bioinformatics solutions that organize information for life sciences, particularly through its Coremine platform, which connects medical concepts related to diseases, drugs, and treatments. Their focus on personalized medicine and innovative text mining algorithms positions them as a key player in the field of drug discovery.
Reference
Core business
Connect – Discover – Share
iNANOD AS
Oslo, Norway
A
1-10 Employees
-
Key takeaway
iNANOD is a newly established biotech company that leverages nanotechnology to enhance drug delivery in cancer treatment, ensuring targeted and concentrated delivery of therapeutic agents to diseased tissues. Their innovative approach aims to improve the efficacy of cancer therapies, which is highly relevant to the field of AI drug discovery.
Reference
Core business
INANOD - CANCER DRUG DEVELOPMENT
iNANOD AS is a newly established bio-tech company in Oslo, Norway. iNANOD utilizes nanotechnology to improve drug delivery within oncology, allowing for more targeted delivery of cancer medicines.
Hadean Ventures
Oslo, Norway
A
1-10 Employees
2014
Key takeaway
The company is focused on investing in the future of healthcare, which may include advancements in drug discovery and development.
Reference
Core business
Hadean Ventures – Investing in the future of healthcare
Technologies which have been searched by others and may be interesting for you:
When exploring the AI drug discovery industry in Norway, several key considerations emerge. Norway boasts a robust biotechnology sector supported by a strong research environment, with universities and institutions focusing on life sciences and technology. Regulations play a crucial role; compliance with EU standards and local laws is essential for any company operating in this space. The industry faces challenges such as high competition, the need for collaboration between academia and industry, and securing funding for innovative projects. Opportunities abound, particularly in leveraging Norway's rich natural resources and extensive genetic databases to enhance drug discovery processes. Environmental concerns also come into play, as sustainable practices are increasingly prioritized in drug development. The competitive landscape features both established pharmaceutical firms and emerging startups, contributing to a dynamic ecosystem. Global market relevance is significant, with Norway's AI drug discovery initiatives aligning with international trends towards personalized medicine and the integration of AI technologies. Understanding these factors is crucial for anyone interested in entering or investing in Norway's AI drug discovery sector.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | Norway |
| Amount of fitting manufacturers | 28 |
| Amount of suitable service providers | 14 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1992 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Ai Drug Discovery?
Start-Ups who are working in Ai Drug Discovery are Addwize
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are IT, Software and Services, Other, Biotechnology, Finance and Insurance, Medical
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.